Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
NCT07263308Phase 3Recruiting
- Sponsor
- Capital Medical University
- Start
- Dec 2025
- Primary completion
- Jun 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of albumin (human) in ischemic stroke, sponsored by Capital Medical University. Started Dec 2025; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07263308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07263308.